(87 days)
Not Found
Not Found
No
The description focuses on the mechanical function of folding and inserting lenses and includes functional and aging studies, with no mention of AI or ML.
No.
The device is used to insert a lens, and does not directly treat a disease or condition.
No
This device is used to fold and insert lenses into the human eye during surgery. It is an surgical instrument, not a device that identifies or interprets medical conditions.
No
The device description explicitly states the device is made from plastic and describes its physical dimensions and components, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "fold and insert STAAR Surgical UV-ELASTICT™ silicone lenses for surgical placement in the human eye." This is a surgical device used in the body, not a device used to examine specimens from the body to provide diagnostic information.
- Device Description: The description reinforces its use as a surgical tool for inserting lenses into the eye.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting markers, or providing diagnostic information about a patient's health status.
IVD devices are used to perform tests on samples taken from the human body to diagnose diseases, monitor health, or screen for conditions. This device is a surgical instrument used to implant a medical device (an intraocular lens).
N/A
Intended Use / Indications for Use
The Disposable MicroSTAART™ Injector (Model MSI-P1) is a device used to fold and insert STAAR Surgical UV-ELASTICT™ silicone lenses for surgical placement in the human eye.
Product codes
86 KYB
Device Description
The Disposable MicroSTAART™ Injector (Model MSI-P1) is used to fold and insert STAAR Surgical UV-ELASTICTM silicone intraocular lenses for surgical placement in the human eye. Like other MicroSTAAR injectors it provides a sterile tubular pathway through a surgical incision, over the iris and into either the ciliary sulcus or the capsular bag of the eye. The Disposable MicroSTAART™ Injector (Model MSI-P1) is made from plastic and the inner dimensions of the delivery pathway, as well as the outer dimensions of the portion that contacts the eye tissues are identical to STAAR Surgical Company's currently marketed injection systems. The Disposable MicroSTAART™Injector (Model MSI-P1) is provided sterile and is designed for single use.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
human eye
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Functional Testing: A functional validation was performed using thirty sterile Disposable MicroSTAAR™ Injectors (Model MSI-P1) to eject thirty UV-ELASTIC™ lenses. The acceptance criteria for the lens ejection test included the following:
- No optic zone lens tears for properly loaded lenses. -
- All post-eiected lenses to meet a minimum resolution > 3.6. -
The lens eiection test results showed no lens tears in addition to meeting the minimum resolution requirements.
Accelerated Aging Study: The following tests were performed on baseline (zero time) and one year accelerated samples as part of the validation:
- Microbial Challenge Dust Drum -
- Dye Penetration -
- -Peel Strength
- Burst
The Microbial Challenge - Dust Drum test reports indicate all samples and negative controls to be "NEGATIVE" and the positive controls to be "POSITIVE" which are acceptable results.
The Dye Penetration test reports indicate all samples as "Pass".
The Peel Strength tests compared the mean maximum seal strength for the baseline and one-year accelerated age samples using the T-test and F-test analysis. The results indicate that the sample means and variances are statistically similar.
The Burst tests compared the baseline and one-year accelerated age samples using the T-test and F-test analysis. The results of the analysis of the large pouch indicate that the sample means and variances are statistically similar. No statistical analysis was required for the small pouch as there were no failures.
Overall, the non-clinical test results demonstrate that the sterilized Disposable MicroSTAAR™ Injector (Model MSI-P1) successfully ejects lenses and the packaging maintains adequate integrity to ensure product sterility for a period of one year.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
MicroSTAART™ Injector System (reusable and disposable)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 886.4300 Intraocular lens guide.
(a)
Identification. An intraocular lens guide is a device intended to be inserted into the eye during surgery to direct the insertion of an intraocular lens and be removed after insertion is completed.(b)
Classification. Class I (general controls). Except when used as folders or injectors for soft or foldable intraocular lenses, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 886.9.
0
DEC 4 1998
:
PREMARKET NOTIFICATION [510(K)] SUMMARY FOR THE DISPOSABLE MicroSTAAR™ INJECTOR SYSTEM
| Trade/Proprietary Name: | Disposable MicroSTAART™ Injector (Model MSI-P1) |
|---|---|
| Common/Usual Name: | Disposable IOL Injector |
| Classification Name: | Foldable Intraocular Lens Injector |
| Submitted by: | STAAR Surgical Company |
| 1911 Walker Avenue | |
| Monrovia, CA 91016 | |
| Phone: (626) 303-7902 | |
| FAX: (626) 930-1423 | |
| Contact Person: | Steven L. Ziemba |
| Vice-President, Regulatory Affairs | |
| Phone: (626) 303-7902 ext. 2308 | |
| Date Summary Prepared: | September 4, 1998 |
| Legally Marketed | |
| Predicate Device: | MicroSTAART™ Injector System (reusable and disposable) manufactured |
| by STAAR Surgical Company. | |
| Intended Use of | |
| the Device:: | The Disposable MicroSTAART™ Injector (Model MSI-P1) is a device used |
| to fold and insert STAAR Surgical UV-ELASTICT™ silicone lenses for | |
| surgical placement in the human eye. | |
| Device Description: | The Disposable MicroSTAART™ Injector (Model MSI-P1) is used to fold |
| and insert STAAR Surgical UV-ELASTICTM silicone intraocular lenses | |
| for surgical placement in the human eye. Like other MicroSTAAR | |
| injectors it provides a sterile tubular pathway through a surgical incision, | |
| over the iris and into either the ciliary sulcus or the capsular bag of the eye. | |
| The Disposable MicroSTAART™ Injector (Model MSI-P1) is made from | |
| plastic and the inner dimensions of the delivery pathway, as well as the | |
| outer dimensions of the portion that contacts the eye tissues are identical to | |
| STAAR Surgical Company's currently marketed injection systems. The | |
| Disposable MicroSTAART™Injector (Model MSI-P1) is provided sterile | |
| and is designed for single use. |
1
1983129
Nonclinical Performance Testing:
Functional Testing: A functional validation was performed using thirty sterile Disposable MicroSTAAR™ Injectors (Model MSI-P1) to eject thirty UV-ELASTIC™ lenses. The acceptance criteria for the lens ejection test included the following:
- No optic zone lens tears for properly loaded lenses. -
- All post-eiected lenses to meet a minimum resolution > 3.6. -
The lens eiection test results showed no lens tears in addition to meeting the minimum resolution requirements.
Accelerated Aging Study: The following tests were performed on baseline (zero time) and one year accelerated samples as part of the validation:
- Microbial Challenge Dust Drum -
- Dye Penetration -
- -Peel Strength
- Burst
The Microbial Challenge - Dust Drum test reports indicate all samples and negative controls to be "NEGATIVE" and the positive controls to be "POSITIVE" which are acceptable results.
The Dye Penetration test reports indicate all samples as "Pass".
The Peel Strength tests compared the mean maximum seal strength for the baseline and one-year accelerated age samples using the T-test and F-test analysis. The results indicate that the sample means and variances are statistically similar.
The Burst tests compared the baseline and one-year accelerated age samples using the T-test and F-test analysis. The results of the analysis of the large pouch indicate that the sample means and variances are statistically similar. No statistical analysis was required for the small pouch as there were no failures.
Overall, the non-clinical test results demonstrate that the sterilized Disposable MicroSTAAR™ Injector (Model MSI-P1) successfully ejects lenses and the packaging maintains adequate integrity to ensure product sterility for a period of one year.
110 G
2
Image /page/2/Picture/1 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo features a stylized eagle with three lines representing its wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
1998 DEC ব
Steven L. Ziemba Vice President, Regulatory Affairs STAAR Surgical Company 1911 Walker Avenue Monrovia, CA 91016
Re: K983129 Trade Name: Disposable MicroSTAAR™ Injector (Model MSI-P1) Regulatory Class: I Product Code: 86 KYB Dated: September 4, 1998 Received: September 8, 1998
Dear Mr. Ziemba:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic OS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 -- Mr. Steven L. Ziemba
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
A. Roerl Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS STATEMENT
1983129 510(k) Number:
Disposable MicroSTAAR™ Injector Device Name:
The Disposable MicroSTAAR™ Injector is a device used to fold and insert Indications For Use: STAAR Surgical Company UV-ELASTIC™ single-piece silicone lenses for surgical placement in the human eye.
PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use ما (per 21 CFR 801.109)
OR
Over-The-Counter Use _ (Optional Format 1/2/96)
Carlisle Bucklew for DEL
(Division Sign-Off)
Division of Ophthalmic Devices 510(k) Number_k 98 3